Atsushi Nohara Selected Research

Xanthomatosis (Xanthoma)

11/2020	A case with familial hypercholesterolemia complicated with severe systemic atherosclerosis intensively treated for more than 30 years.
10/2018	Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
9/2018	Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease.
8/2018	Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.
6/2018	Guidance for Pediatric Familial Hypercholesterolemia 2017.
5/2017	Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
7/2016	A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing.
1/2015	Infantile Cases of Sitosterolaemia with Novel Mutations in the ABCG5 Gene: Extreme Hypercholesterolaemia is Exacerbated by Breastfeeding.
1/2012	Guidelines for the management of familial hypercholesterolemia.
1/2012	Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Nohara Research Topics

Disease

40	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 05/2002
18	Coronary Artery Disease (Coronary Atherosclerosis) 06/2019 - 05/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2015
12	Atherosclerosis 01/2021 - 12/2002
12	Xanthomatosis (Xanthoma) 11/2020 - 06/2005
7	Homozygous Familial Hypercholesterolemia 07/2021 - 02/2012
7	Hypercholesterolemia 08/2016 - 12/2011
6	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2002
6	Hypertriglyceridemia 01/2018 - 05/2005
6	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2015 - 10/2004
5	Hypertension (High Blood Pressure) 10/2020 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 03/2018 - 04/2006
5	Insulin Resistance 01/2013 - 03/2007
4	Acute Coronary Syndrome 12/2021 - 01/2017
4	Stroke (Strokes) 12/2021 - 03/2017
4	Sitosterolemia 08/2020 - 08/2018
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2012
4	Hyperlipidemias (Hyperlipidemia) 08/2018 - 10/2004
4	Dyslipidemias (Dyslipidemia) 11/2014 - 04/2007
3	Fatty Liver 01/2020 - 01/2009
3	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2020 - 01/2009
3	Glucose Intolerance 03/2018 - 07/2011
3	Chronic Renal Insufficiency 03/2017 - 01/2016
3	Pancreatitis 01/2016 - 12/2005
3	Cholesteryl Ester Transfer Protein Deficiency 11/2014 - 02/2008
3	Inflammation (Inflammations) 08/2009 - 12/2004
2	Myocardial Infarction 01/2022 - 12/2021
2	Unstable Angina 01/2022 - 07/2018
2	Neoplasms (Cancer) 10/2020 - 11/2016
2	Diabetes Mellitus 06/2019 - 01/2015
2	Body Weight (Weight, Body) 01/2019 - 01/2015
2	Heart Failure 01/2018 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 07/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2009 - 05/2006
2	Aortic Valve Stenosis (Aortic Stenosis) 05/2009 - 12/2006
1	Collagen Diseases (Collagen Disease) 12/2021
1	Disease Progression 11/2020
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2020

Drug/Important Bio-Agent (IBA)

33	oxidized low density lipoproteinIBA 01/2022 - 12/2002
27	LDL CholesterolIBA 01/2022 - 12/2002
24	LipidsIBA 12/2021 - 01/2004
17	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 12/2002
14	Lipoproteins (Lipoprotein)IBA 04/2019 - 10/2004
14	Triglycerides (Triacylglycerol)IBA 01/2019 - 12/2002
13	LDL Receptors (LDL Receptor)IBA 07/2021 - 12/2002
13	CholesterolIBA 03/2021 - 12/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2021 - 07/2002
8	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 12/2004
7	Proprotein Convertase 9IBA 11/2020 - 07/2011
6	omega-Chloroacetophenone (Mace)IBA 12/2021 - 03/2015
6	ApolipoproteinsIBA 01/2019 - 10/2004
6	HDL CholesterolIBA 07/2018 - 04/2007
5	Apolipoproteins B (ApoB)IBA 01/2021 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2007
4	Ezetimibe (Zetia)FDA Link 09/2018 - 02/2012
4	colestimideIBA 09/2018 - 05/2005
4	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2018 - 12/2005
4	Cholesterol Ester Transfer ProteinsIBA 11/2014 - 12/2002
3	gamma-sitosterol (beta-sitosterol)IBA 08/2020 - 01/2015
3	BMS201038IBA 04/2019 - 04/2017
3	SterolsIBA 12/2018 - 01/2010
3	alirocumabIBA 08/2016 - 12/2015
3	Heparin (Liquaemin)FDA LinkGeneric 04/2016 - 03/2007
3	Insulin (Novolin)FDA Link 01/2013 - 05/2005
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2009 - 12/2004
2	Pharmaceutical PreparationsIBA 04/2019 - 04/2016
2	Phytosterols (Plant Sterols)IBA 09/2018 - 08/2018
2	Lipoprotein(a)IBA 07/2018 - 01/2016
2	Fibric Acids (Fibrates)IBA 01/2017 - 01/2013
2	Lipase (Acid Lipase)FDA Link 04/2016 - 11/2006
2	SteroidsIBA 01/2016 - 07/2015
2	Asparaginase (Elspar)FDA Link 01/2016 - 07/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015 - 06/2005
2	IsotopesIBA 01/2015 - 02/2012
2	VLDL LipoproteinsIBA 02/2012 - 01/2009
2	Rosuvastatin Calcium (Crestor)FDA Link 02/2012 - 01/2004
2	AdipokinesIBA 07/2011 - 01/2011
2	BezafibrateIBA 07/2011 - 05/2011
2	Fenofibrate (CiL)FDA LinkGeneric 07/2011 - 04/2006
2	Apolipoprotein E2IBA 05/2011 - 10/2004
2	Atorvastatin (Lipitor)FDA Link 05/2011 - 05/2005
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 03/2007
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2009 - 12/2004
2	Apolipoproteins E (ApoE)IBA 02/2008 - 10/2004
1	Vitamin E FDA LinkGeneric 01/2019
1	VitaminsIBA 01/2019
1	Essential Fatty AcidsIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	microsomal triglyceride transfer proteinIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 12/2018
1	Apolipoprotein B-48IBA 12/2018
1	PCSK9 InhibitorsIBA 09/2018

Therapy/Procedure

15	Therapeutics 12/2021 - 01/2005
6	Blood Component Removal (Apheresis) 12/2021 - 05/2009
3	Drug Therapy (Chemotherapy) 04/2017 - 05/2009
2	Percutaneous Coronary Intervention 11/2020 - 07/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020 - 07/2018
2	Secondary Prevention 06/2019 - 05/2009
2	Fat-Restricted Diet (Diet, Fat Restricted) 04/2019 - 01/2019
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2015 - 06/2005